naftopidil has been researched along with tadalafil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadekawa, K; Kawamorita, N; Majima, T; Mori, K; Okada, H; Sugaya, K; Tyagi, P; Yoshimura, N; Yoshizawa, T | 1 |
| Fujimura, M; Fukui, T; Oka, M; Oyama, T; Yoshifuji, M; Yoshinaga, R | 1 |
2 other study(ies) available for naftopidil and tadalafil
| Article | Year |
|---|---|
Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury.
Topics: Adrenergic alpha-Antagonists; Animals; Female; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Tadalafil; Urethra; Urinary Bladder; Urination | 2017 |
Comparison of the Effects of Tadalafil and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Electric Stimulation; Indoles; Male; Muscle Contraction; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Seminal Vesicles; Tadalafil; Tamsulosin; Vas Deferens | 2019 |